DrugsControl Media Services

News Detail

Drug sales may rise 6-8 per cent in FY24: Study (13-04-2023)

Mumbai, 12 April 2023: Drug companies are expected to register a 6-8 per cent revenue growth in FY24, primarily driven by steady performance across key markets (the US and India) and recovery in Europe.


According to ICRA, the operating profit margin of the ......
View Details

Source : ICRA Press Release
Biocon icra nlem sensex research and analysis wing China GDP wpi india health news

Related News